Svelta Labs
Svelta Labs science for weight, wellness and skin
Svelta Labs Journal

Svelta Labs Education & Research Journal

Fresh editorial content for peptide research, skincare science, wellbeing categories, Svelta-GPT updates, and research-use product guidance.

Obesity, Sleep Apnoea and Cancer: Revisiting an Interconnected Triad
Weight science 18 Nov 2026

Obesity, Sleep Apnoea and Cancer: Revisiting an Interconnected Triad

A captured review excerpt argues that obesity, obstructive sleep apnoea and cancer form an interconnected triad, and that oxygen-desaturation measures may predict cancer-related outcomes better than the standard apnoea-hypopnoea index.

Hair Loss Concerns with Mounjaro: A Lived Experience Perspective
Wellbeing 18 Nov 2026

Hair Loss Concerns with Mounjaro: A Lived Experience Perspective

Some users report hair loss after increasing their Mounjaro dose, raising questions about this side effect's nature and duration. This article explores the lived experience and current understanding.

What a Reddit Thread on Stomach Cramps During Weight-Loss Treatment Actually Shows
Wellbeing 15 Oct 2026

What a Reddit Thread on Stomach Cramps During Weight-Loss Treatment Actually Shows

A captured Reddit discussion about stomach cramps during weight-loss treatment offers a useful lesson in reading community experience carefully — and in separating it from verified evidence.

Semaglutide and Athletic Performance: A New Clinical Trial in Runners
Research 15 Oct 2026

Semaglutide and Athletic Performance: A New Clinical Trial in Runners

A new randomised placebo-controlled trial will examine how short-term semaglutide affects body composition, muscle function, running economy and performance in well-trained runners.

Brain Stimulation and Weight Loss: What a Phase 2 Trial Explored
Research 15 Oct 2026

Brain Stimulation and Weight Loss: What a Phase 2 Trial Explored

A registered Phase 2 study set out to test whether electrical stimulation of the dorsolateral prefrontal cortex changed food intake and weight over four weeks, alongside weight-loss counselling. Here is what the record actually describes, and what it does not.

Peptide Compounding Market: Regulation and Supply-Chain Readiness
Peptides & Industry

Peptide Compounding Market: Regulation and Supply-Chain Readiness

Interest in peptide compounding raises supply-chain and market questions. An advisory recommendation is not a licence to manufacture approved medicines.

FDA Peptide Compounding Review: The Evidence and Safety Questions
Research & Regulation

FDA Peptide Compounding Review: The Evidence and Safety Questions

The FDA’s July 2026 review concerned ingredients for pharmacy compounding. Its evidence questions differ from approval of a finished medicine.

What Are GLP-1 Receptor Agonists and How Do They Work?
Wellbeing

What Are GLP-1 Receptor Agonists and How Do They Work?

Learn how GLP-1 medicines affect appetite and blood sugar, with examples and a clear distinction between diabetes and weight-management indications.

What Is Cagrilintide? Amylin, CagriSema and Weight-Loss Research
Wellbeing

What Is Cagrilintide? Amylin, CagriSema and Weight-Loss Research

Cagrilintide is an investigational amylin analogue. This guide explains its appetite-related biology, CagriSema trials and the limits of current evidence.

Wolverine Peptide Pen Ingredients: Why the Name Needs Checking
Peptide Science

Wolverine Peptide Pen Ingredients: Why the Name Needs Checking

The earlier article used Wolverine for BPC-157 and TB-500. Svelta’s current Wolverine Recovery Pen lists CJC-1295 no DAC and Ipamorelin, so the distinction matters.

Not Eating Enough During Weight Loss: When to Review Your Diet
Wellbeing

Not Eating Enough During Weight Loss: When to Review Your Diet

Weight management should not mean ignoring nutrition. Review whether your meals meet your needs and seek help if low appetite or restrictive eating makes that difficult.

Weight Loss for Women Over 30: Building a Practical Routine
Wellbeing

Weight Loss for Women Over 30: Building a Practical Routine

Work, family and health can all affect a routine. Focus on realistic changes and individual advice rather than a special protocol or a guaranteed result at a particular age.

Retatrutide and Fatty Liver: What the Phase 2a Trial Found
Wellbeing & Research

Retatrutide and Fatty Liver: What the Phase 2a Trial Found

A phase 2a study measured liver fat in participants with metabolic dysfunction-associated steatotic liver disease. Its results need the study context and clear limits.

Healthy Habits for a 10kg Weight-Loss Goal
Lifestyle & Wellbeing

Healthy Habits for a 10kg Weight-Loss Goal

Small repeatable changes can make a weight-management plan easier to follow. Set an appropriate personal goal and focus on routines rather than a guaranteed transformation.

GHK-Cu Peptide Research: Copper, Collagen and Evidence Limits
Peptides & Regeneration

GHK-Cu Peptide Research: Copper, Collagen and Evidence Limits

GHK-Cu is a copper-binding tripeptide with a long research history. The important distinction is between a measured laboratory result and a proven result for a product.

What Is MOTS-c? Mitochondrial Peptide Research and Its Limits
Wellbeing

What Is MOTS-c? Mitochondrial Peptide Research and Its Limits

MOTS-c is a mitochondrial-derived peptide studied in metabolic signalling. The original cell and mouse findings are a starting point for research, not a personal health promise.

Protein for Weight Loss: Nutrition Beyond Retatrutide Headlines
Wellbeing

Protein for Weight Loss: Nutrition Beyond Retatrutide Headlines

Keep the useful nutrition principles separate from drug claims: plan balanced meals, include varied protein foods and seek individual support when needed.